Home  >  Products  >  BID (BH3 interacting domain death agonist ) Blocking Peptide (the C terminal of BID)(100ug)
BID (BH3 interacting domain death agonist ) Blocking Peptide (the C terminal of BID)(100ug)

BID (BH3 interacting domain death agonist ) Blocking Peptide (the C terminal of BID)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BID Antibody (ARP61037_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61037
Size: 100ug
Weight: 27kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes a death agonist that heterodimerizes with either agonist BAX or antagonist BCL2. The encoded protein is a member of the BCL-2 family of cell death regulators. It is a mediator of mitochondrial damage induced by caspase-8 (CASP8); CASP8 cleaves this encoded protein, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release. Multiple alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been defined.
Alternative names: FP497; MGC15319; MGC42355
See Full Product Listings >